Brain-derived neurotrophic factor is related with adverse cardiac remodeling and high NTproBNP

[1]  H. Völzke,et al.  Association of Brain-Derived Neurotrophic Factor and Vitamin D with Depression and Obesity: A Population-Based Study , 2018, Neuropsychobiology.

[2]  B. Machaliński,et al.  BDNF - A key player in cardiovascular system. , 2017, Journal of molecular and cellular cardiology.

[3]  M. Bahls,et al.  Data on subgroup specific baseline characteristics and serum sphingosine-1-phosphate concentrations in the Study of Health in Pomerania , 2017, Data in brief.

[4]  B. Flath,et al.  Neurocognitive function, brain-derived neurotrophic factor (BDNF) and IL-6 levels in cancer patients with depression , 2015, Journal of Neuroimmunology.

[5]  K. Shimada,et al.  Elevated Circulating Levels of Inflammatory Markers in Patients with Acute Coronary Syndrome , 2015, International journal of vascular medicine.

[6]  Y. Izumiya,et al.  Significance of low plasma levels of brain-derived neurotrophic factor in patients with heart failure. , 2015, The American journal of cardiology.

[7]  U. Förstermann,et al.  Downregulation of BDNF Expression by PKC and by TNF-α in Human Endothelial Cells , 2015, Pharmacology.

[8]  Xian Li,et al.  Tyrosine Kinase Receptor B Protects Against Coronary Artery Disease and Promotes Adult Vasculature Integrity by Regulating Ets1-Mediated VE-Cadherin Expression , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[9]  R. Vasan,et al.  Circulating Brain‐Derived Neurotrophic Factor Concentrations and the Risk of Cardiovascular Disease in the Community , 2015, Journal of the American Heart Association.

[10]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[11]  D. Kass,et al.  Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation , 2015, Autonomic Neuroscience.

[12]  G. Jin,et al.  15-deoxy-Δ12,14-PGJ2 promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis , 2014, International journal of cardiology.

[13]  K. Oba,et al.  Decreased serum brain-derived neurotrophic factor levels are correlated with exercise intolerance in patients with heart failure. , 2013, International journal of cardiology.

[14]  Pradeep J. Nathan,et al.  BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.

[15]  M. Whooley,et al.  Depression and cardiovascular disorders. , 2013, Annual review of clinical psychology.

[16]  K. Hashimoto.  Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression , 2013, Progress in Neurobiology.

[17]  B. Caballero,et al.  Use and interpretation of anthropometry , 2012 .

[18]  M. Thompson,et al.  Brain-Derived Neurotrophic Factor Enhances Calcium Regulatory Mechanisms in Human Airway Smooth Muscle , 2012, PloS one.

[19]  F. Leenen,et al.  Cardioprotective brain mechanisms. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[20]  I. Komuro,et al.  Brain-Derived Neurotrophic Factor Protects Against Cardiac Dysfunction After Myocardial Infarction via a Central Nervous System–Mediated Pathway , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[21]  L. Monteggia,et al.  Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders , 2012, Pharmacological Reviews.

[22]  S. Lavandero,et al.  Impaired cardiac autophagy in patients developing postoperative atrial fibrillation. , 2012, The Journal of thoracic and cardiovascular surgery.

[23]  Yan Liu,et al.  Association of plasma brain-derived neurotrophic factor and cardiovascular risk factors and prognosis in angina pectoris. , 2011, Biochemical and biophysical research communications.

[24]  W. Rathmann,et al.  Cohort profile: the study of health in Pomerania. , 2011, International journal of epidemiology.

[25]  L. Ferrucci,et al.  Circulating Brain-Derived Neurotrophic Factor and Indices of Metabolic and Cardiovascular Health: Data from the Baltimore Longitudinal Study of Aging , 2010, PloS one.

[26]  U. John,et al.  Heart valve sclerosis predicts all-cause and cardiovascular mortality. , 2010, Atherosclerosis.

[27]  Markus Grube,et al.  Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. , 2010, Journal of the American College of Cardiology.

[28]  Y. Béjot,et al.  Serum brain‐derived neurotrophic factor and platelet activation evaluated by soluble P‐selectin and soluble CD‐40‐ligand in patients with acute myocardial infarction , 2009, Fundamental & clinical pharmacology.

[29]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[30]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[31]  Wilfried De Backer,et al.  Body surface area in normal-weight, overweight, and obese adults. A comparison study. , 2006, Metabolism: clinical and experimental.

[32]  J. Bella,et al.  BDNF-mediated enhancement of inflammation and injury in the aging heart. , 2006, Physiological genomics.

[33]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[34]  K. Hirata,et al.  Possible Role of Brain-Derived Neurotrophic Factor in the Pathogenesis of Coronary Artery Disease , 2005, Circulation.

[35]  H. Flor,et al.  Mice with Genetically Altered Glucocorticoid Receptor Expression Show Altered Sensitivity for Stress-Induced Depressive Reactions , 2005, The Journal of Neuroscience.

[36]  L. Manni,et al.  Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. , 2005, International journal of cardiology.

[37]  M. Elia,et al.  Bioelectrical impedance analysis--part I: review of principles and methods. , 2004, Clinical nutrition.

[38]  C. Agardh,et al.  Socio‐demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study , 2003, Diabetes, obesity & metabolism.

[39]  H. Wittchen,et al.  Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI) , 1998, Social Psychiatry and Psychiatric Epidemiology.

[40]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[41]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[42]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[43]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[44]  N. Reichek,et al.  Left Ventricular Hypertrophy: Relationship of Anatomic, Echocardiographic and Electrocardiographic Findings , 1981, Circulation.

[45]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[46]  D. McManus,et al.  Serum brain‐derived neurotrophic factor and risk of atrial fibrillation , 2017, American heart journal.

[47]  Charles J. Stone,et al.  Additive Splines in Statistics , 2015 .

[48]  J. Voigt,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[49]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[50]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[51]  U. John,et al.  Study of Health in Pomerania (SHIP): A health examination survey in an east German region: Objectives and design , 2005, Sozial- und Präventivmedizin.

[52]  R. Krauss,et al.  Diagnosis and management of the metabolic syndrome , 2005 .

[53]  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.

[54]  D. Gurantz,et al.  Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts. , 1999, Circulation research.

[55]  P. B. Eveleth,et al.  Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee , 1996 .

[56]  H. Wittchen.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review. , 1994, Journal of psychiatric research.

[57]  M. Riva,et al.  Cellular Neuroscience Mini Review Article Brain-derived Neurotrophic Factor: a Bridge between Inflammation and Neuroplasticity , 2022 .

[58]  B. Greenberg,et al.  Tumor Necrosis Factor- (cid:97) Upregulates Angiotensin II Type 1 Receptors on Cardiac Fibroblasts , 2022 .